These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6986686)

  • 1. Abrogation of T cell homing by alloantibody.
    Chang AE; Sugarbaker PH
    Transplantation; 1980 Feb; 29(2):127-32. PubMed ID: 6986686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential homing of passively transferred T cells into skin allografts of mice.
    Chang AE; Sugarbaker PH
    Transplantation; 1979 Sep; 28(3):247-52. PubMed ID: 40333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of passive enhancement on graft and host. Graft adaptation by alloantibody as the mechanism of prolonged skin allograft survival.
    McCullough CS; Sugarbaker PH; Matthews W
    Transplantation; 1984 Jan; 37(1):91-6. PubMed ID: 6229914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing alloantibody effective during sensitization but not effector phase of skin graft rejection.
    Sugarbaker PH; Chang AE
    Transplantation; 1979 Jul; 28(1):60-5. PubMed ID: 377597
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts.
    de Waal RM; Capel PJ; Koene RA
    J Immunol; 1980 Feb; 124(2):719-23. PubMed ID: 6985936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged skin allograft survival through enhancement effects on donor tissue.
    Deutsch HL; Edington HD; McCullough CM; Sugarbaker PH
    Transplantation; 1986 Aug; 42(2):200-4. PubMed ID: 3526658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective blockade of IL-15 by soluble IL-15 receptor alpha-chain enhances cardiac allograft survival.
    Smith XG; Bolton EM; Ruchatz H; Wei X; Liew FY; Bradley JA
    J Immunol; 2000 Sep; 165(6):3444-50. PubMed ID: 10975865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro growth of murine T cells. VI. Accelerated skin graft rejection caused by adoptively transferred cells expanded in T cell growth factor.
    Rosenstein M; Eberlein T; Kemeny MM; Sugarbaker PH; Rosenberg SA
    J Immunol; 1981 Aug; 127(2):566-71. PubMed ID: 7019327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperacute rejection of skin allografts in the mouse. Sensitivity of ingrowing skin grafts to the action of alloantibody and rabbit complement.
    Gerlag PG; Koene RA; Hagemann JF; Wijdeveld PG
    Transplantation; 1975 Oct; 20(4):308-13. PubMed ID: 1099736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of alloantibodies on corneal allograft survival.
    Hegde S; Mellon JK; Hargrave SL; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of rejection of organ allografts by alloantibody.
    Morris PJ
    Immunol Rev; 1980; 49():93-125. PubMed ID: 6445324
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
    Dono K; Maki T; Wood ML; Monaco AP
    Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice.
    Wasowska BA; Qian Z; Cangello DL; Behrens E; Van Tran K; Layton J; Sanfilippo F; Baldwin WM
    Transplantation; 2001 Mar; 71(6):727-36. PubMed ID: 11330533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients.
    Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S
    Transplantation; 1998 Dec; 66(12):1587-96. PubMed ID: 9884244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asialo GM1 positive CD8+ T cells induce skin allograft rejection in the absence of the secondary lymphoid organs.
    Yamanokuchi S; Ikai I; Nishitai R; Matsushita T; Sugimoto S; Shiotani T; Yamaoka Y
    J Surg Res; 2005 Nov; 129(1):57-63. PubMed ID: 16140338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice.
    Ohzato H; Monaco AP
    Transplantation; 1992 Dec; 54(6):1090-5. PubMed ID: 1465774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar activities of IgG1 and IgG2 alloantibodies in enhancement of mouse skin grafts and in opsonization.
    Lems SP; Rijke-Schilder TP; Capel PJ; Koene RA
    Transplantation; 1984 Mar; 37(3):291-6. PubMed ID: 6701959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of alloantibodies and suppressor cells in allografted mice treated for passive enhancement.
    Duc HT; Kinsky RG; Monnot P; Voisin GA
    Cell Immunol; 1985 Oct; 95(1):180-94. PubMed ID: 4028170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell responses to alloantigens. III. Prolonged circulation of specific cytotoxic T memory cells following skin allograft rejection in mice.
    Burton RC; Russell PS
    Transplantation; 1981 Nov; 32(5):375-80. PubMed ID: 7036452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressor cells in specific unresponsiveness to skin allografts in ALS-treated, marrow-injected mice.
    Wood ML; Monaco AP
    Transplantation; 1980 Mar; 29(3):196-200. PubMed ID: 6444769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.